Colorectal cancer is a leading cause of cancer-related death in the United States. Numerous effective anticancer drugs have been developed from botanicals, and identifying new herbal sources to develop ideal chemoprevention remains an essential step in advancing the treatment of colorectal cancer. The candidate, Dr. Chong-Zhi Wang, is an experienced phytochemical scientist at University of Chicago. This application describes a development award for Dr. Wang, to successfully achieve his long-term career goals of obtaining the skills necessary to become an independent investigator in biomedical research, concentrating on the efficacy and mechanism of bioactive botanical extracts/compounds for treating colorectal cancer. Training for Dr. Wang will focus on advancing his knowledge of pharmacognosy and metabolism of phytoconstituents, understanding cancer pathophysiology, becoming proficient in biostatistics knowledge, and improving his grant writing ability. The advisory team is composed of senior experts from the University of Chicago and University of Illinois at Chicago. The Primary Mentor Dr. Chun-Su Yuan, a Principal Investigator of NIH Center for Botanical Research on Colorectal Cancer at University of Chicago, will closely direct Dr. Wang's training and research. Preliminary data showed that the different fractions from Scutellaria baicalensis extract (SbE) had opposing effects on human colorectal cancer cells. The hypothesis of this study is that if the baicalin and scutellarein, hydrophilic constituents, are removed from S. baicalensis extract or transformed into lipophilic constituents, the anticancer effects of the extract will increase significantly. The purpose of the research is to develop a new process for preparing an aglycon-rich fraction (ARF) of S. baicalensis extract in improving its anticancer activities and to elucidate the underlying mechanisms.
The specific aims are as follows:
Aim 1. Authentication, extraction and isolation of SbE and preparation of ARF.
Aim 2. Evaluation of the effects of SbE and ARF on colorectal cancer and related mechanisms of action.
Aim 3. Further investigation of ARF-induced apoptotic pathways. Data from this proposed study will have the potential to advance cancer treatment regimens, and improve the quality of life for patients suffering from colorectal cancer. Upon successful completion of this award, Dr. Wang will be fully prepared for his independent investigation of additional pharmacologically based studies using phytoconstituents against colorectal cancer.

Public Health Relevance

Colorectal cancer is a leading cause of cancer related death in the United States. While advances have been made in developing effective treatment strategies for this cancer, chemotherapies are still limited by severe adverse effects and dose-limiting toxicity. This Project will use Scutellaria baicalensis, a Chinese herb medicine, with a new extract process to produce an active fraction, and evaluate the active fraction's anticancer effects on colorectal cancer.

National Institute of Health (NIH)
National Center for Complementary & Alternative Medicine (NCCAM)
Research Scientist Development Award - Research & Training (K01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAT1-PK (09))
Program Officer
Williamson, John S
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Chicago
Schools of Medicine
United States
Zip Code
Wang, Chong-Zhi; Wan, Jin-Yi; Zhang, Chun-Feng et al. (2018) Deglycosylation of wogonoside enhances its anticancer potential. J Cancer Res Ther 14:S594-S599
Wang, Chong-Zhi; Zhang, Chun-Feng; Zhang, Qi-Hui et al. (2018) Fecal metabolomic dataset of American ginseng-treated DSS mice: Correlation between ginseng enteric inflammation inhibition and its biological signatures. Data Brief 21:1403-1408
Wang, C-Z; Huang, W-H; Zhang, C-F et al. (2018) Role of intestinal microbiome in American ginseng-mediated colon cancer prevention in high fat diet-fed AOM/DSS mice [corrected]. Clin Transl Oncol 20:302-312
Tang, Yong-Jun; Hu, Kai; Huang, Wei-Hua et al. (2017) Effects of FMO3 Polymorphisms on Pharmacokinetics of Sulindac in Chinese Healthy Male Volunteers. Biomed Res Int 2017:4189678
Wan, Jin-Yi; Wang, Chong-Zhi; Zhang, Qi-Hui et al. (2017) Significant difference in active metabolite levels of ginseng in humans consuming Asian or Western diet: The link with enteric microbiota. Biomed Chromatogr 31:
Chen, Nai-Tzu; Souris, Jeffrey S; Cheng, Shih-Hsun et al. (2017) Lectin-functionalized mesoporous silica nanoparticles for endoscopic detection of premalignant colonic lesions. Nanomedicine 13:1941-1952
Wang, Chong-Zhi; Yu, Chunhao; Wen, Xiao-Dong et al. (2016) American Ginseng Attenuates Colitis-Associated Colon Carcinogenesis in Mice: Impact on Gut Microbiota and Metabolomics. Cancer Prev Res (Phila) 9:803-811
Yuan, Jinbin; Chen, Yang; Liang, Jian et al. (2016) Component analysis and target cell-based neuroactivity screening of Panax ginseng by ultra-performance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 1038:1-11
Wang, Chong-Zhi; Anderson, Samantha; Yuan, Chun-Su (2016) Phytochemistry and Anticancer Potential of Notoginseng. Am J Chin Med 44:23-34
Du, Wen-Juan; Yang, Xiao-Lin; Song, Zi-Jing et al. (2016) Antitumor Activity of Total Flavonoids from Daphne genkwa in Colorectal Cancer. Phytother Res 30:323-30

Showing the most recent 10 out of 70 publications